Navigation Links
Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study
Date:7/9/2008

COPENHAGEN, Denmark, July 9 /PRNewswire-FirstCall/ -- Summary: Genmab has completed recruitment of patients in the Phase II study of ofatumumab in combination with fludarabine and cyclophosphamide to treat front line CLL.

Genmab A/S (OMX: GEN) announced today it has completed recruitment of 56 patients in the Phase II study of ofatumumab (HuMax-CD20 (R)) in combination with fludarabine and cyclophosphamide (FC) to treat chronic lymphocytic leukemia (CLL) in previously untreated patients.

"We are pleased to complete patient enrollment in the first front line study of ofatumumab and hope to see a positive outcome for the CLL patients in this trial," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab.

Ofatumumab is an investigational fully human, next generation monoclonal antibody that targets a unique epitope of the CD20 molecule on the surface of B-cells. Other anti-CD20 antibodies currently available or in development bind to a different epitope on the CD20 molecule. Ofatumumab is being developed to treat CLL, follicular non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis under a co development and commercialization agreement between Genmab and GlaxoSmithKline. It is not yet approved in any country.

About the trial

Patients in this open label study will be randomized into two treatment groups of 28 patients each. Each patient will receive 6 monthly infusions of either 500 or 1000 mg of ofatumumab in combination with FC. Disease status will be measured every 4 weeks until week 24 according to National Cancer Institute Working Group Guidelines and every 3 months thereafter until disease progression or 24 months. Patients not having progressed on their disease at 24 months will be followed for disease progression at 6 month intervals until 48 months.

The objective of the study is to determine the efficacy of ofatumumab in combination with FC
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genmab Reaches Milestone in Ofatumumab Collaboration
2. Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer
3. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
4. Genmab Announces Updates on Phase III Cancer Studies
5. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
6. Bionomics Achieves US$1 Million Milestone Payment from Genmab
7. DAHANCA Initiates Head and Neck Cancer Study With Genmabs HuMax-EGFr
8. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
9. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
10. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
11. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 The spinal column is one of the ... carried to and from the brain through the column control ... Injury or ailment here can be life altering, and leave ... control over their body. Though back injury and disease can ... are more options available to make things better than ever ...
(Date:8/21/2014)... Aug. 21, 2014 /CNW/ - The Canadian Epilepsy Alliance (CEA) ... series designed to educate children about the most common neurological ... Medikidz Explain Epilepsy comic series tells a fictional story ... middle school while living with epilepsy. "Despite ... is still so much misinformation and lack of awareness out ...
(Date:8/21/2014)... , N.Y. and HAMBURG, Germany , ... announced it is collaborating with Deutsches Elektronen-Synchrotron ( DESY ... Germany , to speed up management and storage ... Big Data and Analytics architecture based on IBM ... per second of data at peak performance and help ...
Breaking Medicine Technology:Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3
... , ... ... ... ...
... , ... ... ... ...
Cached Medicine Technology:Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 2Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 3Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 4Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 5Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 6Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 7Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 8Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 9Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 10Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 11Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 12Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results 13InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 2InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 3InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 4InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 5InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 6InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 7InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 8InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 9InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 10
(Date:8/22/2014)... with severe disabilities and multiple chronic conditions are screened ... disabilities or no chronic conditions, a new study has ... women with moderate disabilities or women with only one ... scientist with the Li Ka Shing Knowledge Institute of ... disabilities often have other measures of social vulnerability, such ...
(Date:8/22/2014)... NY (PRWEB) August 22, 2014 Ticket ... Caputo tickets in Kalamazoo, New Orleans, Albuquerque and Rapid ... death, the “Long Island Medium,” Theresa Caputo, allows just that. ... Island. She is part of a close knit family who ... speaking with a spiritual healer, realized she had a chance ...
(Date:8/22/2014)... “Dr. Luciana Show – Aging and Falling” is currently ... finding it challenging to stay on top of post-production tasks ... of students, so the editing of the episodes will take ... she recently entered it into the festival circuit. , ... actor/screenwriter Gregory Graham , the aging and falling show ...
(Date:8/22/2014)... (ESMO), the leading pan-European organisation representing medical oncology ... individuals receiving the Society,s esteemed annual awards. The ... Joensuu and Peter Boyle on the occasion of ... , Carsten Bokemeyer will receive the ESMO Award ... cancer discovery into real benefit at patient level. ...
(Date:8/22/2014)... approx. 265,000 Danes are acutely admitted to medical departments ... University and Aarhus University Hospital now shows that many ... are sent home again without receiving a diagnosis ... hospitalisation., "Naturally, there is no need for a diagnosis ... is a serious illness. So some patients will always ...
Breaking Medicine News(10 mins):Health News:Women with severe, chronic health issues are screened for breast cancer less often 2Health News:Theresa Caputo Tickets in Kalamazoo at Wings Stadium, Saenger Theatre in New Orleans, Kiva Auditorium in Albuquerque and Rapid City at Don Barnett Arena Now Available 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Many patients are discharged without a diagnosis 2
... , MONDAY, April 23 (HealthDay News) -- Studies that ... are more likely to get published in medical journals ... such as rocking and hand-flapping, new research says. ... medications -- known as selective serotonin reuptake inhibitors (SSRIs) ...
... landmark clinical trial in Canada demonstrated the unequivocal effectiveness ... then the procedure has not been widely adoptedin fact, ... from the University of California, San Francisco (UCSF). ... Neurology , showed that the number of Americans having ...
... at 3 and I will give you the adult compulsive ... in Psychological Science , a journal published by the ... 900 individuals beginning in toddlerhood, the study found that "people ... inattentive, oppositional, and moody than other three-year old children were ...
... April 23, 2012 Most people go through life ... life-altering experience makes those goals become unachievable or even ... Psycho-Oncology by Carsten Wrosch of Concordia University,s ... Development and Catherine Sabiston of McGill,s Department of Kinesiology ...
... Nigeria,s top government officials, civil society leaders and leaders ... vaccine access nationwide, a major step in the fight to ... highest number of child deaths. Among other commitments, the First ... the sustained introduction and scale-up of childhood vaccines as well ...
... Next time you need to choose between vegetable oil and ... reach for the oil. While the question of whether vitamin ... scientific journals and in the news media, scientists at the ... Pharmacy, and the Cancer Institute of New Jersey, believe that ...
Cached Medicine News:Health News:'Publication Bias' Casts Doubt on Value of Antidepressants for Autism 2Health News:'Publication Bias' Casts Doubt on Value of Antidepressants for Autism 3Health News:Brain surgery for epilepsy underutilized 2Health News:Brain surgery for epilepsy underutilized 3Health News:That impulsive, moody preschooler may grow up to be a problem gambler 2Health News:Letting go can boost quality of life 2Health News:Groundbreaking Nigeria summit results in major commitment to reduce child deaths 2Health News:Vitamin E in diet protects against many cancers 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: